𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Search for Breast Cancer Biomarkers in Fractionated Serum Samples by Protein Profiling With SELDI-TOF MS

✍ Scribed by Annemieke W.J. Opstal-van Winden; Jos H. Beijnen; Arnoud Loof; Waander L. van Heerde; Roel Vermeulen; Petra H.M. Peeters; Carla H. van Gils


Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
485 KB
Volume
26
Category
Article
ISSN
0887-8013

No coin nor oath required. For personal study only.

✦ Synopsis


Background

Many high‐abundant acute phase reactants have been previously detected as potential breast cancer biomar‐kers. However, they are unlikely to be specific for breast cancer. Cancer‐specific biomarkers are thought to be among the lower abundant proteins.

Methods

We aimed to detect lower abundant discriminating proteins by performing serum fractionation by strong anion exchange chromatography preceding protein profiling with SELDI‐TOF MS. In a pilot study, we tested the different fractions resulting from fractionation, on several array types. Fraction 3 on IMAC30 and Fraction 6 on Q10 yielded the most discriminative proteins and were used for serum protein profiling of 73 incident breast cancer cases and 73 matched controls.

Results

Eight peaks showed statistically significantly different intensities between cases and controls (P⧁0.05), and had less than 10% chance to be a false‐positive finding. Seven of these were tentatively identified as apolipoprotein C‐II (m/z 8,909), oxidized apolipoprotein C‐II (m/z 8,925), apolipoprotein C‐III (m/z 8,746), fragment of coagulation factor XIIIa (m/z 3,959), heterodimer of apolipoprotein A‐I and apolipoprotein A‐II (m/z 45,435), hemoglobin B‐chain (m/z 15,915), and post‐translational modified hemoglobin (m/z 15,346).

Conclusion

By extensive serum fractionation, we detected many more proteins than in previous studies without fractionation. However, discriminating proteins were still high abundant. Results indicate that either lower abundant proteins are less distinctive, or more rigorous fractionation and selective protein depletion, or a more sensitive assay, are needed to detect lower abundant discriminative proteins.


📜 SIMILAR VOLUMES


Identification of Serum Protein Markers
✍ Lei Lei; Xiao-Jia Wang; Zhi-Guo Zheng; Jian Huang; Wen-Ming Cao; Zhan-Hong Chen; 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 243 KB

## Abstract Surface‐enhanced laser desorption/ionization time‐of‐flight mass spectrometry (SELDI‐TOF MS) was used to screen serum samples to identify protein markers for early breast cancer relapse. We collected 67 serum samples from patients with breast cancer (24 preoperative; 23 postoperative wi